Skip to main content

Full text of "USPTO Patents Application 09916235"

See other formats


Attorney Docket No. 371 67-8040.US01 (13724-850) 



/ 



/ 



IN THE UNITED STATES PATENT AND TRADEMARK OFFICE 



in Re Application of: Johnson etal. 
Application No.: 09/916,235 
Filed: July 25, 2001 

FOR: METHOD FOR DETECTING AND TREATING TUMORS USING 
LOCALIZED IMPEDANCE MEASUREMENT 



EXAMINER: VRETTAKOS, P. 
ART UNIT: 3739 
CONFIRMAITONNO. 6858 



Commissioner for Patents 
P. O. Box 1450 
Alexandria, VA 22313-1450 



\ 

^ CI 



Kb 



CP 



Sir: 



TRANSMITTAL FOR INFORMATION DISCLOSURE STATEMENT 

Applicant(s) hereby submit the following documents for the above-entitled application. 
Transmitted herewith are the following : 

1. Information Disclosure Statement 

2. FormPTO-1449 

3. Cited references 

4. Postcard receipt. 

5. Check in the amount of $180.00 for fee due. 



Applicant(s) believe that no fee is due, however, please charge any underpayment in fees for timely 
filing of this transmittal and enclosures to Deposit Account No. 50-2207. 

Respectfully submitted, 
Perkins Coie LLP 



Date: (YW^ 2&7/xd\ 




Correspondence Address : 
Customer No. 22918 
Phone: (650)838-4410 




Attorney Docket No. 37167-8040.US01 (13724-850) 
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE 



RE Application of: Johnson et al. 
Serial No.: 09/916,235 
FILED: July 25, 2001 

For: method for detecting and treating tumors 

USING LOCALIZED IMPEDANCE MEASUREMENT 



Examiner: Vrettakos,P. 
Art Unit: 3739 
confirmation no. 6858 



§ 

o 

s 

o 



a. 



, Information Disclosure Statement After First Office Action but Before 

j Final Action or Notice of Allowance-37 CFR 1.97(c) 

Commissioner for Patents 
P. O. Box 1450 
Alexandria, VA 22313-1450 

Sir: 

1. Timing of Submission 

This information disclosure is being filed after three months of the filing date of 
this application or after the mailing date of the first office action on the merits, 
whichever occurred last, but before the mailing date of either a final action 
under 37 CFR 1.113 or a Notice of Allowance under 37 CFR 1.311, whichever 
occurs first. The references listed on the enclosed Form PTO-1449 may be 
material to the examination of this application; the Examiner is requested to 
make them of record in the application. 

2. Cited Information 

(3 Copies of the following references are enclosed: 

□ References marked with a double asterisk (**). 

□ References marked by asterisks 
I3 All Cited References 

□ Copies of the following references can be found in parent U.S. 
Application No. *: 

□ All cited references 

□ References marked with a single asterisk (*). 

□ The following: 

3. Effect of Information Disclosure Statement (37 CFR 1.97(h)) 

This Information Disclosure Statement is not to be construed as a 
representation that: (i) a search has been made; (ii) additional information 
material to the examination of this application does not exist; (iii) the information, 
protocols, results and the like reported by third parties are accurate or enabling; 
or (iv) the cited information is, or is considered to be, material to patentability. In 
addition, applicant does not admit that any enclosed item of information 
05/27/8004 EAREGAY1 00000097 09916235 



r 

o 



01 FC:1806 



180.00 OP 



1 



Attorney Docket No. 37167-8040.US01 (13724-850) j 

o 

r~ 
O 



ZD 

£ m 

constitutes prior art to the subject invention and specifically reserves the right to S< pj-j 
demonstrate that any such reference is not prior art. £ — - — 

jH CD 

4. Fee Payment ^ 5> [Tl 
S Applicant elects to pay the fee under 37 CFR 1.1 7(p) in the amount of % ^ 
$180.00. ° 

S Enclosed is a check including the amount of $180 for the fee due. 

^ The Commissioner is hereby authorized to charge any deficiency in fees to 
ensure timely submission of these papers to Deposit Account No. 50-2207. 

5. Patent Term Adjustment (37 CFR 1.704(d)) 

□ The undersigned states that each item of information submitted herewith 
was cited in a communication from a foreign patent office in a counterpart 
application and that this communication was not received by any individual 
designated in 37 C.F.R. § 1.56(c) more than thirty days prior to the filing of this 
statement. 37 C.F.R. § 1.704(d). 

Respectfully submitted, 
Perkins Coie LLP 

Date: ^ 25,7flfi* QjfjfaJh 

Jao^uqffne F. Mahoney 
Registration No. 48,390 

Correspondence Address: 

Customer No. 22918 
Tel: 650 838-4410 



2 




^FORMATION DISCLOSURE 
STATEMENT BY APPLICANT 

/^Form PTO-1449 (Modified) 
se several sheets if necessary) 



COMPLETE IF KNOWN 



Application Number 



Filed 



First Named Inventor 



Group Art Unit 



Examiner Name 



Atty Dkt No. 



09/916,235 



July 25, 2001 



1 



Johnson et al. 



3739 



TO 



Vrettakos, P. 



o 
rn 



37167-8040.US01 



-3- 



411 



Confirmation No. 



6858 



43 



U.S. PATENT DOCUMENTS 


Examiner 
Initials 


Cite 
No. 


U.S. Patent or Application 


Name of Patentee or Inventor 
of Cited Document 


Date of 
Publication or 
Filing Date 
of Cited 
Document 


Pages, Columns, Lines, 
Where Relevant 
Figures Appear 


Kind Code 

NUMBER (if known) 






5,536,267 




Edwards et al. 


07/16/96 








5,620,479 




Diederich 


04/15/97 








5,683,384 




Gough et al. 


11/04/97 








5,800,484 




Gough et al. 


09/01/98 








a fieri nQii 




Sherman 


04/18/00 








6,066,134 




Eggers et al. 


05/23/00 








6,200,314 


B1 


Sherman 


03/13/01 








6,296,636 


B1 


Cheng et al. 


10/02/01 








6,485,487 


B1 


Sherman. 


11/26/02 








6,488,678 


B2 


Sherman 


12/03/02 








6,558,378 


B1 


Sherman et al. 


05/06/03 








6,616,657 


B2 


Simpson et al. 


09/09/03 








6,673,070 


B2 


Edwards et al. 


01/06/04 








6,712,811 


B2 


Underwood et al. 


03/30/04 








US20020161361 


A1 


Sherman et al. 


10/31/02 








US200301 09871 


A1 


Johnson et al. 


06/12/03 





OTHER PRIOR ART-NON PATENT LITERATURE DOCUMENTS 



Examiner 
Initials 



Cite 
No. 



Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item 
(book, magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume issue number(s), publisher, city 
and/or country where published. 



FOREIGN PATENT DOCUMENTS 



Examiner 
Initial 



Cite 
No. 



Foreign Patent or Application 



Office NUMBER 



Kind Code 
(if known) 



Name of Patentee or 

Applicant 
of Cited Document 



Date of 
Publication or 
Filing Date 
of Cited 
Document 



Pages, Columns, Lines, 
Where Relevant 
Figures Appear 



EXAMINER 


DATE CONSIDERED 


'EXAMINER: Initial if reference considered, whether or not criteria is in conformance with MPEP 609. Draw line through citation if not in conformance and 
not considered. Include copy of this form with next communication to application(s).